drugset / Trial / NCT00077818

Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)

NCT00077818

Phase 4 Completed Sanofi
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine the efficacy and safety of enoxaparin compared to unfractionated heparin (UFH) for patients diagnosed with Acute Coronary Syndrome (ACS) in the emergency department (ED). Efficacy is assessed by using a composite score consisting of 30-day all-cause mortality, non-fatal myocardial infarction (MI) and recurrent angina requiring revascularization.

Timeline

Start
2002-06
Primary completion
2005-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified